160 related articles for article (PubMed ID: 35567760)
1. Defining pathogenicity of NOTCH2 variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients.
Li ZD; Abuduxikuer K; Wang L; Hao CZ; Zhang J; Wang MX; Li LT; Qiu YL; Xie XB; Lu Y; Wang JS
Liver Int; 2022 Aug; 42(8):1836-1848. PubMed ID: 35567760
[TBL] [Abstract][Full Text] [Related]
2. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.
Gilbert MA; Bauer RC; Rajagopalan R; Grochowski CM; Chao G; McEldrew D; Nassur JA; Rand EB; Krock BL; Kamath BM; Krantz ID; Piccoli DA; Loomes KM; Spinner NB
Hum Mutat; 2019 Dec; 40(12):2197-2220. PubMed ID: 31343788
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Novel Heterozygous Variant c.1076c>T p. (Ser359Phe) chr1: 120512166 in NOTCH2 Gene, Type 2 Alagille Syndrome Causing Neonatal Cholestasis: A Case Report.
Uddin MS; Al Fulayyih S; Al Denaini FF; Al Hatlani MM
Am J Case Rep; 2022 Oct; 23():e935840. PubMed ID: 36201396
[TBL] [Abstract][Full Text] [Related]
4. Alagille syndrome caused by NOTCH2 mutation presented atypical pathological changes.
ShenTu Y; Mi X; Tang D; Jiang Y; Gao L; Ma X; Zhou B; Yang W; Shi J; Lan D; Chen G; Gong L
Clin Chim Acta; 2021 Oct; 521():258-263. PubMed ID: 34332988
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, outcomes, and genetic analysis in Korean children with Alagille syndrome.
Cho JM; Oh SH; Kim HJ; Kim JS; Kim KM; Kim GH; Yu E; Lee BH; Yoo HW
Pediatr Int; 2015 Aug; 57(4):552-7. PubMed ID: 25676721
[TBL] [Abstract][Full Text] [Related]
6. Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features.
Lin HC; Le Hoang P; Hutchinson A; Chao G; Gerfen J; Loomes KM; Krantz I; Kamath BM; Spinner NB
Am J Med Genet A; 2012 May; 158A(5):1005-13. PubMed ID: 22488849
[TBL] [Abstract][Full Text] [Related]
7. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
Andersson ER; Chivukula IV; Hankeova S; Sjöqvist M; Tsoi YL; Ramsköld D; Masek J; Elmansuri A; Hoogendoorn A; Vazquez E; Storvall H; Netušilová J; Huch M; Fischler B; Ellis E; Contreras A; Nemeth A; Chien KC; Clevers H; Sandberg R; Bryja V; Lendahl U
Gastroenterology; 2018 Mar; 154(4):1080-1095. PubMed ID: 29162437
[TBL] [Abstract][Full Text] [Related]
8. Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
Kohut TJ; Gilbert MA; Loomes KM
Semin Liver Dis; 2021 Nov; 41(4):525-537. PubMed ID: 34215014
[TBL] [Abstract][Full Text] [Related]
9. NOTCH2 mutations in Alagille syndrome.
Kamath BM; Bauer RC; Loomes KM; Chao G; Gerfen J; Hutchinson A; Hardikar W; Hirschfield G; Jara P; Krantz ID; Lapunzina P; Leonard L; Ling S; Ng VL; Hoang PL; Piccoli DA; Spinner NB
J Med Genet; 2012 Feb; 49(2):138-44. PubMed ID: 22209762
[TBL] [Abstract][Full Text] [Related]
10. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes.
Schindler EA; Gilbert MA; Piccoli DA; Spinner NB; Krantz ID; Loomes KM
Am J Med Genet A; 2021 Mar; 185(3):719-731. PubMed ID: 33369123
[TBL] [Abstract][Full Text] [Related]
11. Alagille Syndrome: Current Understanding of Pathogenesis, and Challenges in Diagnosis and Management.
Ayoub MD; Kamath BM
Clin Liver Dis; 2022 Aug; 26(3):355-370. PubMed ID: 35868679
[TBL] [Abstract][Full Text] [Related]
12. Alagille Syndrome.
Mitchell E; Gilbert M; Loomes KM
Clin Liver Dis; 2018 Nov; 22(4):625-641. PubMed ID: 30266153
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characterization of Alagille Syndrome in Patients with Cholestatic Liver Disease.
Semenova N; Kamenets E; Annenkova E; Marakhonov A; Gusarova E; Demina N; Guseva D; Anisimova I; Degtyareva A; Taran N; Strokova T; Zakharova E
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511516
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and gene mutation analysis of patients with Alagille syndrome].
Liu XG; Wei HJ; Liu P; Liu X; Tang L; Yang Y; Li YR
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2454-2459. PubMed ID: 34399559
[No Abstract] [Full Text] [Related]
15. Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene.
Hatim O; Pavlinov I; Xu M; Linask K; Beers J; Liu C; Baumgärtel K; Gilbert M; Spinner N; Chen C; Zou J; Zheng W
Stem Cell Res; 2023 Dec; 73():103231. PubMed ID: 37890331
[TBL] [Abstract][Full Text] [Related]
16. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.
McDaniell R; Warthen DM; Sanchez-Lara PA; Pai A; Krantz ID; Piccoli DA; Spinner NB
Am J Hum Genet; 2006 Jul; 79(1):169-73. PubMed ID: 16773578
[TBL] [Abstract][Full Text] [Related]
17. Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1.
Brooks BM; Pradhan M; Cheng YS; Gorshkov K; Farkhondeh A; Chen CZ; Beers J; Liu C; Baumgaertel K; Rodems S; Zheng W
Stem Cell Res; 2021 Jul; 54():102447. PubMed ID: 34198154
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary and Pancreatic: Hepatic arterioportal fistula: A novel and treatable feature of Alagille syndrome.
Lopez RN; Al Rawahi Y; Stormon M; Chennapragada M; Ooi CY
J Gastroenterol Hepatol; 2019 Apr; 34(4):633. PubMed ID: 30565330
[No Abstract] [Full Text] [Related]
19. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
20. Alagille syndrome: pathogenesis, diagnosis and management.
Turnpenny PD; Ellard S
Eur J Hum Genet; 2012 Mar; 20(3):251-7. PubMed ID: 21934706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
